文献速递糖尿病肥胖与代谢综合征

青少年居家连续血糖监测口服葡萄糖耐量试验的可行性、可接受性与有效性

Feasibility, Acceptability, and Validity of Home Continuous Glucose Monitoring-Based Oral Glucose Tolerance Test in Youth.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在儿科临床与转化研究中心开展前瞻性观察研究,39名8至18岁超重/肥胖且伴有糖尿病前期范围糖化血红蛋白、空腹血糖或口服葡萄糖耐量试验2小时血糖和/或至少一项指南推荐的2型糖尿病危险因素的青少年,完成研究中心75g 2小时口服葡萄糖耐量试验(research-OGTT)与居家盲法连续血糖监测口服葡萄糖耐量试验(home-OGTT)。居家口服葡萄糖耐量试验可接受性高,但仅77%获得有效数据;与研究中心口服葡萄糖耐量试验相比,敏感度和阴性预测值高(≥80%),特异度和阳性预测值低。

要点

  • 居家连续血糖监测口服葡萄糖耐量试验可接受性高(92%评价极好/很好)。
  • 仅77%参与者获得有效居家口服葡萄糖耐量试验数据。
  • 居家口服葡萄糖耐量试验敏感度和阴性预测值≥80%,特异度和阳性预测值低。

核心结论

  • 居家口服葡萄糖耐量试验可接受,但需改进策略以精确捕捉葡萄糖摄入时间以提高可行性。
  • 在将连续血糖监测用作青少年2型糖尿病筛查方法前,可能需要定义替代的血糖异常阈值。

研究设计与样本

  • 前瞻性观察研究,在儿科临床与转化研究中心开展。
  • 纳入39名8至18岁超重/肥胖且伴有糖尿病前期范围糖化血红蛋白、空腹血糖或口服葡萄糖耐量试验2小时血糖和/或至少一项指南推荐的2型糖尿病危险因素的青少年。
  • 参与者完成两次75g 2小时口服葡萄糖耐量试验:一次在研究中心使用血清样本(research-OGTT),一次在家使用盲法连续血糖监测(home-OGTT)。

主要发现

  • 39名参与者中54%为女性;33%为黑人,8%为西班牙裔/拉丁裔,13%为多种族,46%为非西班牙裔白人;年龄14.6±2.0岁;平均体重指数37.0±6.7 kg/m2。
  • 糖化血红蛋白5.7%±0.4%,空腹血糖85.7±8.0 mg/dL,2小时血糖115.9±25.9 mg/dL。
  • 30名(77%)有有效居家口服葡萄糖耐量试验数据。
  • 可接受性高:92%评价极好/很好,8%评价中立。
  • 由于居家口服葡萄糖耐量试验平均值较高,敏感度和阴性预测值高(≥80%),而特异度(空腹:10%;2小时:25%)和阳性预测值(空腹:3.6%,2小时:18.2%)低。

关键数值与推荐

  • 血糖异常定义:空腹血糖≥100 mg/dL;2小时血糖≥140 mg/dL。
  • 可行性定义为有有效居家口服葡萄糖耐量试验数据的百分比(报告日期/时间、返回发射器)。
  • 可接受性通过调查和访谈回答评估。
  • 有效性通过居家与研究中心口服葡萄糖耐量试验血糖异常的敏感度、特异度、阳性预测值和阴性预测值评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Home-based approaches to type 2 diabetes (T2D) screening in youth may facilitate early diagnosis. OBJECTIVE: This work aimed to evaluate feasibility, acceptability, and validity of a continuous glucose monitoring (CGM)-based oral glucose tolerance test (OGTT). METHODS: A prospective observational study was conducted at a pediatric clinical and translational research center. Participants were youth aged 8 to 18 years with overweight/obesity and prediabetes-range glycated hemoglobin A1c (HbA1c), fasting glucose, or 2-hour glucose on OGTT, and/or one or more guideline-based T2D risk factors. Participants completed two 75 g 2-hour OGTT 1) at the research center using serum samples (research-OGTT), and 2) at home using blinded CGM (home-OGTT). Feasibility: Percentage with valid home-OGTT data (date/time reported, transmitter returned). Acceptability: Survey and interview responses. Validity: Sensitivity, specificity, positive- and negative predictive value (PPV, NPV) of home- vs research-OGTT dysglycemia (fasting ≥100 mg/dL; 2-hour ≥140 mg/dL). RESULTS: Thirty-nine youth (54% female; 33% Black, 8% Hispanic/Latinx, 13% multiracial, 46% non-Hispanic White; age 14.6 ± 2.0 years; mean body mass index 37.0 ± 6.7 kg/m2) participated. HbA1c was 5.7% ± 0.4%, fasting glucose 85.7 ± 8.0 mg/dL, and 2-hour glucose 115.9 ± 25.9 mg/dL. Thirty (77%) had valid home-OGTT data. Acceptability was high (92% excellent/great, 8% neutral). Due to higher average values on home-OGTT, sensitivity and NPV were high (≥80%), while specificity (fasting: 10%; 2-hour: 25%) and PPV (fasting: 3.6%, 2-hour: 18.2%) were low. CONCLUSION: Home-OGTT was acceptable, but strategies to precisely capture glucose ingestion timing could improve feasibility. Alternate dysglycemia thresholds may need to be defined prior to using CGM as a method for T2D screening in youth.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rodriguez Gonzalez A, Harrison C, Hewitt B, et al. Feasibility, Acceptability, and Validity of Home Continuous Glucose Monitoring-Based Oral Glucose Tolerance Test in Youth. J Clin Endocrinol Metab. 2025. PMID: 39657252. doi:10.1210/clinem/dgae845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。